• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Life sciences challenge tech in global innovation

Life sciences challenge tech in global innovation

May 26, 2015 By MassDevice Contributors Network

Life sciences challenge tech in global innovation

(Reuters) — The life sciences industry is increasingly taking over from the tech sector in driving global innovation, according to a Thomson Reuters analysis of global patents.

With more patents applied for or granted in 2014 than in any other year in history, humankind has never been more inventive, whether in designing driverless cars, discovering new drugs for cancer or building bionic limbs.

But growth in innovation has nonetheless slowed, with worldwide patent volume up 3% last year, the smallest annual rise since the end of the global recession in 2009. Previous years have seen near double-digit percentage increases.

While part of that may be due to tighter patenting rules in the U.S., there are also signs of more fundamental shifts, with the volume of published scientific literature – a precursor to patents – down 22% across 12 industries.

Significantly, patents for semiconductors fell 5% in 2014. That may spell trouble for other areas, since microchips form a bedrock for innovations such as wearable tech, big data and the so-called Internet-of-things, which allows wireless communication between appliances.

Still, with more than 2.1 million unique inventions recorded across industries last year, the world is not exactly short of new ideas.

Major sectors showing impressive patent growth in 2014 included pharmaceuticals and biotechnology, where inventions rose 12 and 7% respectively, according to the 2015 State of Innovation report published today.

There was also a marked increase in food, beverages and tobacco, up 21%, and in cosmetics and well-being, up 8%.

These sectors also highlight the convergence of industries and the emergence of products such as nutraceuticals – foods and drinks with potential health benefits – and cosmeceuticals, the combination of cosmetics and pharmaceuticals.

Some of the world’s biggest companies are embracing this blurring of boundaries, notably Samsung Electronics (LON:BC94), which is among the top 25 patent assignees in nine of the 12 industries analysed in the report.

In addition to watching a Samsung TV and using a Samsung phone, the South Korean group also wants consumers to take Samsung-manufactured prescription drugs, consume Samsung energy drinks and wear Samsung make-up.

Its broad push, following a bruising patent battle with Apple (NSDQ:AAPL), reflects a growing determination by Asian players to stake their claim on the knowledge economy.

China, too, is a rising force in the patenting landscape, led by companies including Huawei and ZTE, as well as institutions such as the Chinese Academy of Sciences.

Filed Under: News Well Tagged With: Innovation

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy